Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Managing Dry Eye Disease over Time: An Italian Consensus Conference
share announcement

Managing Dry Eye Disease over Time: An Italian Consensus Conference

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: closed (20 April 2024) | Viewed by 3207

Special Issue Editor

Prof. Dr. Giuseppe Giannaccare

E-Mail Website
Guest Editor
Department of Ophthalmology, University Magna Græcia of Catanzaro, 88100 Catanzaro, CZ, Italy
Interests: cornea; clinical ophthalmology; glaucoma; dry eye; retinal diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

While procedures for the correct diagnosis of dry eye disease (DED) have been discussed in depth in the recent literature, the appropriate management of these patients over time has not been investigated thoroughly, with this aspect being crucial due to, typically, dry eye being a chronic recurrent disease. The aim of the Italian Consensus "P.I.C.A.S.S.O." (Partners Italiani per la Correzione delle Alterazioni del Sistema Superficie Oculare/Italian Partners for the Correction of Ocular Surface Alterations) was to provide general ophthalmologists with practical flow charts in order to help them anticipate possible flare-ups of the disease and to correctly manage DED patients over time. Aside from the description of the methodology and the results of the Italian Delphi Consensus on the management of DED over time, the following items have been discussed: (1) the impact of external stimuli and their management; (2) managing the ocular surface of patients before and after ocular surgery; (3) management of eyelid-related problems; (4) management of ocular surface inflammation; (5) way of improving patients' adherence to therapy; (6) way of improving patients' satisfaction.

Prof. Dr. Giuseppe Giannaccare
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dry eye disease
  • consensus
  • treatment
  • management
  • ocular surface

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Editorial

Jump to: Other

2 pages, 166 KiB  
Editorial
Special Issue “Managing Dry Eye Disease over Time: An Italian Consensus Conference”
by Pasquale Aragona, Giuseppe Giannaccare and Maurizio Rolando
J. Clin. Med. 2022, 11(9), 2507; https://doi.org/10.3390/jcm11092507 - 29 Apr 2022
Cited by 1 | Viewed by 976
Abstract
Dry eye disease (DED) is a chronic, progressive, highly prevalent condition affecting 5 to 33% of the global adult population [...] Full article
(This article belongs to the Special Issue Managing Dry Eye Disease over Time: An Italian Consensus Conference)

Other

Jump to: Editorial

7 pages, 836 KiB  
Opinion
Dealing with the Persistent Pathogenic Issues of Dry Eye Disease: The Importance of External and Internal Stimuli and Tissue Responses
by Maurizio Rolando, Stefano Barabino, Giuseppe Giannaccare and Pasquale Aragona
J. Clin. Med. 2023, 12(6), 2205; https://doi.org/10.3390/jcm12062205 - 13 Mar 2023
Cited by 2 | Viewed by 1395
Abstract
The immune system plays a central role in protecting the ocular surface from exogenous and endogenous insults, maintaining tissue homeostasis thanks to the mechanism of para-inflammation. This physiological adaptive response may induce resident macrophages/monocytes to produce cytokines and growth factors in order to [...] Read more.
The immune system plays a central role in protecting the ocular surface from exogenous and endogenous insults, maintaining tissue homeostasis thanks to the mechanism of para-inflammation. This physiological adaptive response may induce resident macrophages/monocytes to produce cytokines and growth factors in order to promote epithelial cell recovery. In case of well-controlled para-inflammation, caused by a low amount of stress, cell viability and function are maintained. When stress becomes too intense, there is a response characterized by the activation of autophagic pathways and consequent cell death. Dysregulated homeostasis and chronic sub-clinical inflammation are the starting points for the development of a stable, chronic inflammatory disease, which leads to ocular surface damage, and, in turn, to the onset or progression of chronic dry eye disease (DED). The long-term management of DED should consider all of the pathogenic issues involved in the disease, including the control of persistent external or internal stresses that are capable of activating and maintaining the para-inflammatory adaptive mechanisms, potentially leading to full-blown inflammation. Dysregulated para-inflammation can be corrected by means of the prolonged use of tear substitutes containing minimal doses of safe corticosteroids or other anti-inflammatory molecules (e.g., corticosteroid, cyclosporine) in order to re-equilibrate ocular surface homeostasis. Full article
(This article belongs to the Special Issue Managing Dry Eye Disease over Time: An Italian Consensus Conference)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop